Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2018
Pharma News, 2018
Body-clock study could pave way for new asthma treatment: UK expert
LONDON, Sept.
GSK says U.S. FDA wants more information on pulmonary drug
LONDON (Reuters) - GlaxoSmithKline said on Friday that U.
AstraZeneca’s first Breakthrough Therapy Designation for a respiratory medicine
AstraZeneca and its partner Amgen Inc.
Chinese researchers identify potential new antibiotic
LONDON, Sept.
Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod
Perrigo Company plc PRGO announced that the FDA has approved store brand over-the-counter ("OTC") equivalent of Johnson & Johnson JNJ owned Imodium Multi-Symptom Relief tablet.
Vertex Completes Enrollment of Two Phase 3 Studies of VX-659 in Triple Combination with Tezacaftor and Ivacaftor for the Treatment of Cystic Fibrosis
BOSTON, MA, USA I September 06, 2018 I Vertex Pharmaceuticals Incorporated (Nasdaq.
ITF Pharma Announces FDA Approval Of TIGLUTIK™ (Riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)
BERWYN, PA, USA I September 6, 2018 I ITF Pharma, a U.
BTG buys Irish med device group Novate
Specialist healthcare group BTG has snapped up med tech group Novate Medical in a deal potentially worth $150 million.
Gilead, Galapagos’ filgotinib succeeds in PhII ankylosing spondylitis trial
A mid-stage trial assessing Gilead and Galapagos’ JAK 1 inhibitor filgotinib in ankylosing spondylitis has hit its targets.
GlaxoSmithKline to cut 650 US jobs, reinvest in R & D
RALEIGH, N.
Walking 20 minutes a day cuts women's heart failure risk by 25%, first ever study on the topic reveals
Walking more - not faster - can significantly lower the risk of heart failure in older women, according to the first ever study on the subject.
Novartis unloads U.S. assets at loss to bargain-hunting Aurobindo
ZURICH/BENGALURU (Reuters) - New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is selling U.
20
21
22
23
24
25
26
27
28
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds
